Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Interest & Investment Income (2019 - 2025)

Pulmonx (LUNG) has disclosed Interest & Investment Income for 7 consecutive years, with $611000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest & Investment Income fell 51.85% to $611000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $3.2 million, a 41.64% decrease, with the full-year FY2024 number at $5.1 million, down 9.11% from a year prior.
  • Interest & Investment Income was $611000.0 for Q3 2025 at Pulmonx, down from $723000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.5 million in Q4 2023 to a low of $94000.0 in Q4 2021.
  • A 5-year average of $776631.6 and a median of $748000.0 in 2022 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: soared 1000.0% in 2021, then crashed 51.85% in 2025.
  • Pulmonx's Interest & Investment Income stood at $94000.0 in 2021, then skyrocketed by 695.74% to $748000.0 in 2022, then skyrocketed by 106.02% to $1.5 million in 2023, then plummeted by 32.19% to $1.0 million in 2024, then tumbled by 41.53% to $611000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Interest & Investment Income are $611000.0 (Q3 2025), $723000.0 (Q2 2025), and $864000.0 (Q1 2025).